AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
Who should be screened for asymptomatic carotid artery stenosis? Experience from the western New York stroke screening program
Authors: Qureshi, AI Janardhan, V Bennett, SE Luft, RR Hopkins, LN Guterman, LR
Citation: Ai. Qureshi et al., Who should be screened for asymptomatic carotid artery stenosis? Experience from the western New York stroke screening program, J NEUROIMAG, 11(2), 2001, pp. 105-111
Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures
Authors: Qureshi, AI Suri, MFK Khan, J Sharma, M Olson, K Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures, J NEURO-ONC, 51(2), 2001, pp. 151-158
Percutaneous transpedicular polymethyl methacrylate vertebroplasty for thetreatment of spinal compression fractures - Comment
Authors: Andrews, B Benzel, EC Fessler, RG Guterman, LR
Citation: B. Andrews et al., Percutaneous transpedicular polymethyl methacrylate vertebroplasty for thetreatment of spinal compression fractures - Comment, NEUROSURGER, 49(5), 2001, pp. 1114-1115
Carotid endarterectomy: Can we select surgical candidates at high risk forstroke and low risk for perioperative complications?
Authors: Lanzino, G Couture, D Andreoli, A Guterman, LR Hopkins, LN
Citation: G. Lanzino et al., Carotid endarterectomy: Can we select surgical candidates at high risk forstroke and low risk for perioperative complications?, NEUROSURGER, 49(4), 2001, pp. 913-923
Risk factors for subarachnoid hemorrhage
Authors: Qureshi, AI Suri, MFK Yahia, AM Suarez, JI Guterman, LR Hopkins, LN Tamargo, REJ
Citation: Ai. Qureshi et al., Risk factors for subarachnoid hemorrhage, NEUROSURGER, 49(3), 2001, pp. 607-612
Absence of early proinflammatory cytokine expression in experimental intracerebral hemorrhage
Authors: Qureshi, AI Suri, FK Ling, GSF Khan, J Guterman, LR
Citation: Ai. Qureshi et al., Absence of early proinflammatory cytokine expression in experimental intracerebral hemorrhage, NEUROSURGER, 49(2), 2001, pp. 416-420
Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke
Authors: Qureshi, AI Ali, Z Suri, MFK Kim, SH Shatla, AA Ringer, AJ Lopes, DK Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke, NEUROSURGER, 49(1), 2001, pp. 41-48
Intraarterial recombinant tissue plasminogen activator for ischemic stroke: An accelerated dosing regimen - In reply
Authors: Qureshi, AI Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Intraarterial recombinant tissue plasminogen activator for ischemic stroke: An accelerated dosing regimen - In reply, NEUROSURGER, 49(1), 2001, pp. 229-229
Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke
Authors: Ringer, AJ Qureshi, AI Fessler, RD Guterman, LR Hopkins, LN
Citation: Aj. Ringer et al., Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke, NEUROSURGER, 48(6), 2001, pp. 1282-1288
Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement
Authors: Qureshi, AI Ali, Z Suri, MFK Kim, SH Fessler, RD Ringer, AJ Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement, NEUROSURGER, 48(5), 2001, pp. 998-1004
Treating complex nervous system vascular disorders through a "needle stick": Origins, evolution, and future of neuroendovascular therapy
Authors: Hopkins, LN Lanzino, G Guterman, LR
Citation: Ln. Hopkins et al., Treating complex nervous system vascular disorders through a "needle stick": Origins, evolution, and future of neuroendovascular therapy, NEUROSURGER, 48(3), 2001, pp. 463-475
Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage
Authors: Qureshi, AI Ling, GSF Khan, J Suri, MFK Miskolczi, L Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage, CRIT CARE M, 29(1), 2001, pp. 152-157
Role of conventional angiography in evaluation of patients with carotid artery stenosis demonstrated by Doppler ultrasound in general practice
Authors: Qureshi, AI Suri, FK Ali, Z Kim, SH Fessler, RD Ringer, AJ Guterman, LR Budny, JL Hopkins, LN
Citation: Ai. Qureshi et al., Role of conventional angiography in evaluation of patients with carotid artery stenosis demonstrated by Doppler ultrasound in general practice, STROKE, 32(10), 2001, pp. 2287-2291
Frequency and predictors for angiographically improved inflow of contrast medium after carotid angioplasty and stenting
Authors: Luft, AR Qureshi, AI Suri, MFK Janardhan, V Guterman, LR Hopkins, LN
Citation: Ar. Luft et al., Frequency and predictors for angiographically improved inflow of contrast medium after carotid angioplasty and stenting, NEURORADIOL, 43(10), 2001, pp. 877-883
Endovascular treatment of intracranial aneurysms by using Guglielmi detachable coils in awake patients: safety and feasibility
Authors: Qureshi, AI Suri, MFK Khan, J Kim, SH Fessler, RD Ringer, AJ Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Endovascular treatment of intracranial aneurysms by using Guglielmi detachable coils in awake patients: safety and feasibility, J NEUROSURG, 94(6), 2001, pp. 880-885
Cocaine use and the likelihood of nonfatal myocardial infarction and stroke - Data from the Third National Health and Nutrition Examination survey
Authors: Qureshi, AI Suri, MFK Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Cocaine use and the likelihood of nonfatal myocardial infarction and stroke - Data from the Third National Health and Nutrition Examination survey, CIRCULATION, 103(4), 2001, pp. 502-506
Ineffective secondary prevention in survivors of cardiovascular events in the US population - Report from the Third National Health and Nutrition Examination Survey
Authors: Qureshi, AI Suri, MFK Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Ineffective secondary prevention in survivors of cardiovascular events in the US population - Report from the Third National Health and Nutrition Examination Survey, ARCH IN MED, 161(13), 2001, pp. 1621-1628
Patient selection, complications, and periprocedural considerations in carotid artery stenting
Authors: Fessler, RD Qureshi, AI Ringer, AJ Guterman, LR Hopkins, LN
Citation: Rd. Fessler et al., Patient selection, complications, and periprocedural considerations in carotid artery stenting, CURRENT STATUS OF CAROTID BIFURCATION ANGIOPLASTY AND STENTING, 2001, pp. 131-152
Acute interventions for ischemic stroke: Present status and future directions
Authors: Qureshi, AI Ringer, AJ Suri, MFK Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Acute interventions for ischemic stroke: Present status and future directions, J ENDOVAS T, 7(5), 2000, pp. 423-428
Cervical carotid revascularization
Authors: Guterman, LR Fessler, RD Hopkins, LN
Citation: Lr. Guterman et al., Cervical carotid revascularization, NEUROSURG C, 11(1), 2000, pp. 39
Angioscopy-assisted aneurysm clipping - In reply
Authors: Lanzino, G Miskolczi, L Guterman, LR Hopkins, LN
Citation: G. Lanzino et al., Angioscopy-assisted aneurysm clipping - In reply, NEUROSURGER, 47(3), 2000, pp. 792-793
Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries - Comment
Authors: Hopkins, LN Qureshi, AI Guterman, LR
Citation: Ln. Hopkins et al., Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries - Comment, NEUROSURGER, 47(2), 2000, pp. 344-344
Intraarterial recombinant tissue plasminogen activator for ischemic stroke: An accelerating dosing regimen
Authors: Qureshi, AI Suri, MFK Shatla, AA Ringer, AJ Fessler, RD Ali, Z Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Intraarterial recombinant tissue plasminogen activator for ischemic stroke: An accelerating dosing regimen, NEUROSURGER, 47(2), 2000, pp. 473-476
A grading scale to predict outcomes after intra-arterial thrombolysis for stroke complicated by contrast extravasation
Authors: Mericle, RA Lopes, DK Fronckowiak, MD Wakhloo, AK Guterman, LR Hopkins, LN
Citation: Ra. Mericle et al., A grading scale to predict outcomes after intra-arterial thrombolysis for stroke complicated by contrast extravasation, NEUROSURGER, 46(6), 2000, pp. 1307-1314
Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: Preliminary experience
Authors: Qureshi, AI Suri, MFK Khan, J Fessler, RD Guterman, LR Hopkins, LN
Citation: Ai. Qureshi et al., Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: Preliminary experience, NEUROSURGER, 46(6), 2000, pp. 1316-1324
Risultati: 1-25 | 26-44